Skip to main content
Clinical Trials/NCT05159401
NCT05159401CompletedNot Applicable

The Use of Vibrational Methods of Influencing the Lungs to Restore Their Functional State After Major Reconstructive Cardiac Surgery

Petrovsky National Research Centre of Surgery1 site in 1 country240 target enrollmentStarted: January 18, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
240
Locations
1
Primary Endpoint
the minute inspiratory lung volume

Study Overview

Brief Summary

There will be formed of groups for application of vibration methods on the lungs: the method of vibroacoustic lung massage using the "BARK VibroLUNG" device; the method of oscillating PEP therapy using Acapella DH Green; the method of hardware stimulation of cough with a mechanical insufflator-aspirator Comfort Cough Plus (Comfortable cough Plus). As a control group, classical manual chest massage with percussion and verbal stimulation of cough against the background of chest compressions with a total duration of 15 minutes will be used

Detailed Description

The patient signs an informed consent to participate in the study after 10-12 hours tracheal extubation and transfer of the patient to spontaneous respiration. The application of one or another method of influence is carried out by the method of random sampling (the envelope method). Next, a session is conducted using one of the methods of vibrational respiratory therapy. We are exploring the gas composition of arterial blood is examined, spirometry, and the respiratory rate is measured after 20 minutes of the procedure. Further, respiratory therapy sessions are repeated 3 times a day for three days

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age from 18 years to 80 years inclusive.
  • Performed cardiac surgery in IC conditions.
  • The patient's consent to participate in this study.

Exclusion Criteria

  • Lack of productive contact with the patient
  • Any disorder in the central nervous system in the perioperative period (acute cerebrovascular accident, coma, posthypoxic encephalopathy), being on a ventilator.
  • Unstable hemodynamics or hemodynamically significant rhythm disturbances
  • Shocks of various etiologies
  • Inability to provide respiratory protection, high risk of aspiration
  • Refusal of the patient to participate in this study

Outcomes

Primary Outcomes

the minute inspiratory lung volume

Time Frame: hospitalisation period, an average of 1 week

Comparison of minute inspiratory lung volume befor/after research using a spirometer

arterial blood oxygenation level

Time Frame: hospitalisation period, an average of 1 day

Comparison arterial blood oxygenation level before/after researchin the study of arterial blood

SpO2 more than 92%

Time Frame: hospitalisation period, an average of 3 day

Comparison of SpO2 by pulse oximeter befor/after research (SpO2\>92%)

Secondary Outcomes

  • the number of complications(hospitalisation period, an average of 1 week)
  • assessment of the duration of hospital stay(hospitalisation period, an average of 1 week)

Investigators

Sponsor
Petrovsky National Research Centre of Surgery
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Aleksandr Eremenko

Clinical Professor

Petrovsky National Research Centre of Surgery

Study Sites (1)

Loading locations...

Similar Trials